Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
KEY PRODUCTS
Reset all filters
01 1Malladi Drugs & Pharmaceuticals Limited
Reset all filters
01 1D-PSEUDOEPHEDRINE SULFATE
Reset all filters
01 1India
Reset all filters
01 1Active
Reset all filters
01 1Complete
Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
GDUFA
DMF Review : Complete
Rev. Date : 2023-05-29
Pay. Date : 2023-05-24
DMF Number : 16147
Submission : 2002-09-05
Status : Active
Type : II
20
Malladi Drugs And Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
One of their notable products is D-PSEUDOEPHEDRINE SULFATE, with a corresponding US DMF Number 16147.
Remarkably, this DMF maintains an Active status since its submission on September 05, 2002, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 29, 2023, and payment made on May 24, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II